Skip to main content
Yuyu Pharma, Inc. logo

Yuyu Pharma, Inc. — Investor Relations & Filings

Ticker · 000220 ISIN · KR7000220004 KO Manufacturing
Filings indexed 304 across all filing types
Latest filing 2023-07-11 Major Shareholding Noti…
Country KR South Korea
Listing KO 000220

About Yuyu Pharma, Inc.

https://www.yuyu.co.kr/

Yuyu Pharma, Inc., established in 1941, is a healthcare company focused on the development, manufacturing, and marketing of pharmaceutical products. The company is committed to creating innovative therapeutics to address healthcare challenges and improve quality of life. Its research and development efforts are concentrated on key therapeutic areas, with a notable emphasis on treatments for central nervous system disorders, including Alzheimer's disease. The company operates through several divisions, including Yuyu Healthcare, which provides pharmaceutical-standard Original Design Manufacturer (ODM) and Original Equipment Manufacturer (OEM) services.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership by major shareholders and special related parties, including reasons for changes such as mergers and stock transfers. This type of document is classified as a Major Shareholding Notification (MRQ) in the provided schema.
2023-07-11 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Yuyu Pharma. It details specific changes in share ownership, including a decrease due to a merger, and lists the holdings of major shareholders. This type of filing is a standard regulatory disclosure regarding significant shareholding changes and ownership structure, which falls under the 'Major Shareholding Notification' category.
2023-07-11 Korean
주식소각결정
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Yuyu Pharma regarding a decision to cancel (retire) treasury shares. It details the number of shares to be cancelled, the method of acquisition (already held treasury shares), and the expected date of cancellation. This falls under the category of capital changes or share buyback/cancellation activities. Given the specific nature of cancelling own shares, 'POS' (Transaction in Own Shares) is the most accurate classification.
2023-07-05 Korean
합병등종료보고서(합병)
M&A Activity Classification · 100% confidence The document is a 'Merger Completion Report' (합병등종료보고서) filed by Yuyu Pharmaceutical. It details the finalization of a merger process, including the timeline, legal status, and post-merger financial summary. In the context of corporate filings, documents detailing the completion of M&A activities are classified under M&A Activity (TAR).
2023-07-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the shareholding status, changes in ownership, and collateral agreements of major shareholders. This falls under the category of Major Shareholding Notification.
2023-06-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea used when an entity's shareholding in a listed company crosses specific thresholds (typically 5% or more). This document specifically details the shareholding changes of Rhinos Asset Management in Yuyu Pharma. This falls under the 'Major Shareholding Notification' category.
2023-06-23 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.